C12N 2770/32061
Methods of inactivation or attenuation
C12N2770/32061 (Methods of inactivation or attenuation) appears on 14 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 21
- Assignees
- 12
- Inventors
- 69
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 2 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 3 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Senecavirus A virus strains and immunogenic compositions therefrom6 Jan 2026US 12,514,917 B2South Dakota Board of Regents
- Recombinant nucleic acid of Seneca valley virus, recombinant vaccine strain and preparation method and use thereof30 Jan 2024US 11,883,482 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Attenuated viruses useful for vaccines2 Nov 2021US 11,162,080 B2The Research Foundation for The State University of New York
- Methods for viral inactivation and other adventitious agents22 Jan 2019US 10,184,106 B2Genentech, Inc.
- Methods of making modified viral genomes17 Jul 2018US 10,023,845 B2The Research Foundation for The State University of New York
- Methods for viral inactivation and other adventitious agents3 Apr 2025US 2025/0109376 A1Genentech, Inc.
- Coxsackievirus b4 strain and application thereof9 Jan 2025US 2025/0009867 A1Institute of Medical Biology, Chinese Academy of Medical Sciences
- Methods for viral inactivation and other adventitious agents19 Sep 2024US 2024/0309314 A1Genentech, Inc.
- Attenuated viruses useful for vaccines11 Jul 2024US 2024/0228981 A1The Research Foundation for The State University of New York
- Encapsulated rna polynucleotides and methods of use11 Apr 2024US 2024/0115636 A1ElevateBio Technologies, Inc.
Most cited
By later US patents
- Glutaric acid virucidal processes and compositions19US 4,767,788 ASterling Drug Inc. · 1988
- Attenuated viruses useful for vaccines13US 9,476,032 B2The Research Foundation for The State University of New York · 2016
- Benzyl alcohol virucidal process9US 4,200,655 ASterling Drug Inc. · 1980
- Seneca Valley virus based compositions and methods for treating disease5US 7,638,318 B2Norvartis AG · 2009
- Vaccine against avian encephalomyelitis4US 5,208,023 AMinister of Agriculture, Fisheries & Food in Majesty's Government of Great Britain · 1993